{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:58:34Z","timestamp":1790744314297,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Managing the critically ill patient with infection is complex, requiring clinicians to synthesize considerable information relating to antimicrobial efficacy and treatment duration. The use of biomarkers may play an important role in identifying variation in treatment response and providing information about treatment efficacy. Though a vast number of biomarkers for clinical application have been described, procalcitonin and C\u2010reactive protein (CRP) are the most thoroughly investigated in the critically ill. However, the presence of heterogeneous populations, variable end points, and incongruent methodology in the literature complicates the use of such biomarkers to guide antimicrobial therapy. This review focuses on an appraisal of evidence for use of procalcitonin and CRP to optimize antimicrobial duration of therapy (DOT) in critically ill patients. Procalcitonin\u2010guided antimicrobial therapy in mixed critically ill populations with varying degrees of sepsis appears to be safe and might assist in reducing antimicrobial DOT. Compared to procalcitonin, fewer studies exist examining the impact of CRP on antimicrobial DOT and clinical outcomes in the critically ill. Procalcitonin and CRP have been insufficiently studied in many key intensive care unit populations, including surgical patients with concomitant trauma, renally insufficient populations, the immunocompromised, and patients with septic shock. We believe the available evidence is not strong enough to warrant routine use of procalcitonin or CRP to guide antimicrobial DOT in critically ill patients with infection. So long as its limitations are recognized, procalcitonin could be considered to tailor antimicrobial DOT on a case\u2010by\u2010case basis in the critically ill patient.<\/jats:p>","DOI":"10.1002\/phar.2834","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:32:10Z","timestamp":1686389530000},"page":"935-949","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Biomarkers in the intensive care setting: A focus on using procalcitonin and C\u2010reactive protein to optimize antimicrobial duration of therapy"],"prefix":"10.1002","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7710-7824","authenticated-orcid":false,"given":"Benjamin A.","family":"August","sequence":"first","affiliation":[{"name":"Critical Care, Henry Ford Hospital  Detroit Michigan USA"},{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Science Wayne State University  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-7710","authenticated-orcid":false,"given":"Pramodini B.","family":"Kale\u2010Pradhan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Science Wayne State University  Detroit Michigan USA"},{"name":"Ascension St. John Hospital  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-785X","authenticated-orcid":false,"given":"Christopher","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Science Wayne State University  Detroit Michigan USA"},{"name":"Ascension St. John Hospital  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Infection Prevention and Antimicrobial Stewardship Ascension St. John Hospital  Detroit Michigan USA"},{"name":"Wayne State University School of Medicine  Detroit Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2717"},{"issue":"12","key":"e_1_2_7_3_1","article-title":"Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open forum","volume":"5","author":"Sakr Y","year":"2018","journal-title":"Infect Dis"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004777"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2194"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1696689"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06956-y"},{"issue":"3","key":"e_1_2_7_8_1","first-page":"367","article-title":"Antimicrobial stewardship using biomarkers: accumulating evidence for the critically ill","volume":"11","author":"Kyriazopoulou E","year":"2022","journal-title":"Antibiot Basel Switz"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2019.08.003"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu732"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e31817c966f"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-1181"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005337"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00053209"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1238OC"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-008-0432-1"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.03.027"},{"issue":"3","key":"e_1_2_7_18_1","first-page":"143","article-title":"Procalcitonin\u2010guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross\u2010over, interventional study","volume":"5","author":"Chomba RN","year":"2020","journal-title":"South Afr J Surg Suid\u2010Afr Tydskr Vir Chir"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318251517a"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1483OC"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc7903"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002186"},{"issue":"9","key":"e_1_2_7_23_1","first-page":"562","article-title":"The comparison of Procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit","volume":"53","author":"Najafi A","year":"2015","journal-title":"Acta Med Iran"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00053-0"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e110"},{"issue":"5","key":"e_1_2_7_26_1","first-page":"507","article-title":"Serum Procalcitonin as a biomarker to determine the duration of antibiotic therapy in adult patients with sepsis and septic shock in intensive care units: a prospective study","volume":"25","author":"Vishalashi SG","year":"2021","journal-title":"Indian J Crit Care Med Peer\u2010Rev off Publ Indian Soc Crit Care Med"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61879-1"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc13157"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2125-7"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002953"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004267"},{"issue":"1","key":"e_1_2_7_32_1","first-page":"37","article-title":"Effectiveness of procalcitonin\u2010guided antibiotic therapy to shorten treatment duration in critically\u2010ill patients with bloodstream infections: a systematic review and meta\u2010analysis","volume":"28","author":"Robati Anaraki M","year":"2020","journal-title":"Infez Med"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1932462"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc1843"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002321"},{"issue":"10","key":"e_1_2_7_36_1","first-page":"814","article-title":"Daily monitoring of biomarkers of sepsis in complicated long\u2010term ICU\u2010patients: can it support treatment decisions?","volume":"76","author":"Iapichino G","year":"2010","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138150"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-020-02494-y"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000226413.54364.36"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.134.1.81"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2018.04.228"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520260039030"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181ec173d"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz274"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70323-7"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa096"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1644"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828e969f"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02946-y"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0839"},{"issue":"1","key":"e_1_2_7_53_1","first-page":"69","article-title":"Procalcitonin, C\u2010reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis","volume":"72","author":"Castelli GP","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.20344\/amp.12143"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2022.2037701"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc8872"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.124"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3800-2"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2014-0607"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2004.10.010"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1918OC"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc12787"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:07:03Z","timestamp":1761052023000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1002\/phar.2834"],"URL":"https:\/\/doi.org\/10.1002\/phar.2834","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"2023-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}